$StarHub(CC3.SG)$ Why hasn't there been any news of dividends?

$HPH Trust USD(NS8U.SG)$
Go to Moon 🌙

$Reddit(RDDT.US)$
The forum-based website and app, which was founded in 2005, is issuing 22 million class A shares at $34 per share.....
The online discussion site went public on Thursday with an offering of 22 million shares at $34 each, including 15.3 million new shares. The rest were sold by existing shareholders.
The stock opened for trading at $47 and finished the first day of trading at just over $50, for a gain of 48% relative to the IPO price. On a fully diluted basis, that gives Red...

$ABVC BioPharma(ABVC.US)$
Today we are proud to announce that its CEO, Dr. Uttam Patil
Selected by CEO Insights Asia Magazine as one of Taiwan's top ten CEOs in 2024. This recognition is a testament to Dr. Patil's outstanding leadership, innovative vision, and significant contributions to the company. Dr. Patil is so confident about the company's future that he owns stock options without getting paid. In his first year as CEO of the company, the company's common stock price rose, social media influence increased, and a renewed focus on its essential products.
After receiving his doctorate degree in chemistry from National Tsing Hua University, he worked as a postdoctoral researcher at National Taiwan Normal University.

$ABVC BioPharma(ABVC.US)$
ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology,
Proudly announced today that its CEO, Dr. Uttam Patil,
was selected as one of the Top 10 CEOs in Taiwan 2024 by CEO Insights Asia Magazine. This recognition is a testament to Dr. Patil's outstanding leadership, innovative vision, and significant contributions to the Company. Dr. Patil is confiden...

$ABVC BioPharma(ABVC.US)$
newsfilter.io
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars.......

$ABVC BioPharma(ABVC.US)$
A clinical-stage biopharmaceutical company dedicated to developing treatment solutions in oncology/hematology, neurology, and ophthalmology, today announced that one of its subsidiaries, AIBTL BioPharma Inc. (AIBL), has signed an agreement to exchange 100% ownership of certain real estate for 1,533,333 AIBL shares per share at a price of $5 per share. According to third party valuations, the property is worth approximately $7.6 million.
“We are very pleased that AIBL has reached this agreement and valuation. ABVC and its subsidiary BioLite, Inc., each own 23 million AIBL shares, and we believe this agreement will add hundreds of millions of dollars in additional value to these assets. We also think this deal proves why ABVC's current market cap of $12 million is undervalued by several orders of magnitude,” said ABVC CEO Dr. Uttam Patil. He further stated, “Real estate values usually increase over a long period of time. Owning this land will enable AVBC and AIBL to save costs in the future by growing plants and maintaining quality by owning farms with controlled conditions, which is critical to our medicines. The cost of manufacturing our medicines will be reduced, providing a more cost effective way to bring our products to market.”
...

$ABVC BioPharma(ABVC.US)$
ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that one of its subsidiaries, AiBtl BioPharma Inc. (AIBL), entered into an Agreement to exchange a 100% ownership stake in certain real estate for 1,533,333 shares of AIBL stock at $5 per share. The property is valued at approximately $7.6 million based on a third-party valuat...